Core Insights - The successful registration of the "Xingjie Large Model" by Fangzhou Jianke marks a significant advancement in the "AI + chronic disease management" sector, transitioning from traditional passive services to proactive insights and personalized solutions driven by AI [1][2][4] Group 1: Company Developments - Fangzhou Jianke has developed the "Xingjie Large Model," which has received national registration, enhancing its capabilities in chronic disease management [1][2] - The company is one of the few internet medical enterprises with "dual model" empowerment, utilizing both the "Xingjie Large Model" and the "Xinshi Medical Large Model" to innovate in the "AI + chronic disease management" field [2][3] - The CEO, Dr. Xie Fangmin, emphasized that true AI empowerment is about making health care proactive, predictive, and ubiquitous [1] Group 2: Technological Innovations - The "Xingjie Large Model" is built on three innovative pillars: technological breakthroughs, application model innovation, and operational efficiency improvements, which collectively enhance service experience [4][5] - The model features deep emotional perception and intent reasoning capabilities, allowing it to accurately identify user emotions and anticipate needs, thus enabling "answering before being asked" [4] - It transitions service interactions from a focus on functionality to an emphasis on user experience, utilizing multimodal technology for more natural interactions [4][5] Group 3: Market Positioning and Collaborations - Fangzhou Jianke has expanded its "AI + chronic disease management" ecosystem through strategic partnerships with leading pharmaceutical companies, aiming to create benchmarks in "AI + specialized disease management" [7] - The company has successfully implemented intelligent service loops in various specialized disease scenarios, such as weight management and psoriasis management, showcasing the clear value of AI technology [7] - The ongoing development of the "H2H" model reflects the company's commitment to integrating advanced technology with healthcare services, aligning with national policies on technological innovation and chronic disease management [8]
响应“人工智能+”国家行动，方舟健客（06086）“杏捷大模型”通过国家备案，为AI+慢病管理注入新动能